CDI remains an urgent public health threat and continues to be the most frequent cause of diarrhea among hospitalized patients and overall hospital-acquired infection in the United States.
Jonathan Lapin, PharmD
Advertisement
Articles by Jonathan Lapin, PharmD
This highlighted study looks at using these 2 therapies concurrently for this infection.
Advertisement
Latest Updated Articles
Double Trouble: Assessing the Impact of Combining Daptomycin and Fosfomycin for MRSA BacteremiaPublished: September 18th 2020 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Phase 3 Trial Confirms Superior Efficacy of Oral Pritelivir for Refractory HSV in Immunocompromised Patients
2
Developing the Next Generation of Rifamycins for Non-TB Mycobacteria in a Post-Antibiotic Era
3
Higher Acceptability of 1 Injectable in First Head-to-Head Comparison of Long-Acting PrEP
4
